Document is current
Any future updates will be listed below
-
Authors
Murata, Kozue
Takamura, Kanae
Watanabe, Risa
Nagashima, Akitomo
Miyauchi, Miho
Miyauchi, Yoshiteru
Masumoto, Hidetoshi https://orcid.org/0000-0002-4059-2827
-
Funding
Funding for this research was provided by:
Research funding provided by Mitsubishi Chemical Corporation
- License Information
-
More Information
Article History
Received: 11 October 2024
Accepted: 27 May 2025
First Online: 25 June 2025
Declarations
:
: The iPS cells used in this study (201B6) were established by Kyoto University under appropriate ethical approval []. For their use in this research, the providing institution did not require approval from the ethics committee of the using institution (Research Ethics Committee 1 of RIKEN Kobe Branch).
: Not applicable.
: This work was supported by research funding and reagents provided by Mitsubishi Chemical Corporation. Co-authors Watanabe, Nagashima, Miyauchi and Miyauchi are employees of Mitsubishi Chemical Corporation and were involved in study design. However, they did not participate in data collection and interpretation for the key experiments differentiating cardiovascular cells from stem cells, nor in drafting the manuscript section describing those experiments.
